StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2022 it was -$3.48M. The highest annual figure on record is -$3.48M in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$3.48M–
FY2021Dec 31, 2021-$24.58M–
FY2020Dec 31, 2020-$15.87M–
FY2015Dec 31, 2015-$6.38M–
FY2014Dec 31, 2014-$14.05M–
FY2013Dec 31, 2013-$12.68M–
FY2012Dec 31, 2012-$11.63M–
FY2011Dec 31, 2011-$16.36M–
FY2010Dec 31, 2010-$7.59M–

More CervoMed figures

See a number that looks wrong?